Dupilumab as an effective therapy for eosinophilic esophagitis in pediatric patients weighing less than 15 kilograms

Documenti analoghi

• Barriers to treatment adherence in pediatric eosinophilic esophagitis
  di: Julia Primo, et al.
  Pubblicazione: (2025)
• Impact of gender, race, and age of onset on the phenotype and comorbidities of pediatric eosinophilic esophagitis
  di: Kyle McKeown, et al.
  Pubblicazione: (2024)
• A novel variant BCL11B mutation in a pediatric patient with difficult‐to‐treat eosinophilic esophagitis
  di: Nikita Lalchandani Day, et al.
  Pubblicazione: (2024)
• Subthreshold eosinophilia during food impaction may mask eosinophilic esophagitis: A pediatric case series
  di: Mark Mahon, et al.
  Pubblicazione: (2025)
• Case series: Joubert syndrome and eosinophilic esophagitis
  di: Jonathon Schening, et al.
  Pubblicazione: (2026)